Global Plasma-derived Factor VIII Market Growth 2020-2025
According to this study, over the next five years the Plasma-derived Factor VIII market will register a xx%% CAGR in terms of revenue, the global market size will reach $ xx million by 2025, from $ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Plasma-derived Factor VIII business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Plasma-derived Factor VIII market by product type, application, key manufacturers and key regions and countries.
This study specially analyses the impact of Covid-19 outbreak on the Plasma-derived Factor VIII, covering the supply chain analysis, impact assessment to the Plasma-derived Factor VIII market size growth rate in several scenarios, and the measures to be undertaken by Plasma-derived Factor VIII companies in response to the COVID-19 epidemic.
Segmentation by : breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.
200IU
250IU
Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.
Hospital
Pharmacy
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Takeda
Octapharma
Grifols
Greencross
CSL
Hualan Bio
Kedrion
RAAS
BPL
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Plasma-derived Factor VIII consumption (value & volume) by key regions/countries, and , history data from 2015 to 2019, and forecast to 2025.
To understand the structure of Plasma-derived Factor VIII market by identifying its various subsegments.
Focuses on the key global Plasma-derived Factor VIII manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Plasma-derived Factor VIII with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Plasma-derived Factor VIII submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Plasma-derived Factor VIII Consumption 2015-2025
2.1.2 Plasma-derived Factor VIII Consumption CAGR by Region
2.2 Plasma-derived Factor VIII Segment 2
2.2.1 200IU
2.2.2 250IU
2.3 Plasma-derived Factor VIII Consumption 2
2.3.1 Global Plasma-derived Factor VIII Consumption Market Share 2 (2015-2020)
2.3.2 Global Plasma-derived Factor VIII Revenue and Market Share 2 (2015-2020)
2.3.3 Global Plasma-derived Factor VIII Sale Price 2 (2015-2020)
2.4 Plasma-derived Factor VIII Segment 2
2.4.1 Hospital
2.4.2 Pharmacy
2.5 Plasma-derived Factor VIII Consumption 2
2.5.1 Global Plasma-derived Factor VIII Consumption Market Share 2 (2015-2020)
2.5.2 Global Plasma-derived Factor VIII Value and Market Share 2 (2015-2020)
2.5.3 Global Plasma-derived Factor VIII Sale Price 2 (2015-2020)
3 Global Plasma-derived Factor VIII by Company
3.1 Global Plasma-derived Factor VIII Sales Market Share by Company
3.1.1 Global Plasma-derived Factor VIII Sales by Company (2018-2020)
3.1.2 Global Plasma-derived Factor VIII Sales Market Share by Company (2018-2020)
3.2 Global Plasma-derived Factor VIII Revenue Market Share by Company
3.2.1 Global Plasma-derived Factor VIII Revenue by Company (2018-2020)
3.2.2 Global Plasma-derived Factor VIII Revenue Market Share by Company (2018-2020)
3.3 Global Plasma-derived Factor VIII Sale Price by Company
3.4 Global Plasma-derived Factor VIII Manufacturing Base Distribution, Sales Area, by Company
3.4.1 Global Plasma-derived Factor VIII Manufacturing Base Distribution and Sales Area by Company
3.4.2 Players Plasma-derived Factor VIII Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Plasma-derived Factor VIII by Regions
4.1 Plasma-derived Factor VIII by Regions
4.2 Americas Plasma-derived Factor VIII Consumption Growth
4.3 APAC Plasma-derived Factor VIII Consumption Growth
4.4 Europe Plasma-derived Factor VIII Consumption Growth
4.5 Middle East & Africa Plasma-derived Factor VIII Consumption Growth
5 Americas
5.1 Americas Plasma-derived Factor VIII Consumption by Countries
5.1.1 Americas Plasma-derived Factor VIII Consumption by Countries (2015-2020)
5.1.2 Americas Plasma-derived Factor VIII Value by Countries (2015-2020)
5.2 Americas Plasma-derived Factor VIII Consumption 2
5.3 Americas Plasma-derived Factor VIII Consumption 2
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
5.8 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Plasma-derived Factor VIII Consumption by Regions
6.1.1 APAC Plasma-derived Factor VIII Consumption by Regions (2015-2020)
6.1.2 APAC Plasma-derived Factor VIII Value by Regions (2015-2020)
6.2 APAC Plasma-derived Factor VIII Consumption 2
6.3 APAC Plasma-derived Factor VIII Consumption 2
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions
7 Europe
7.1 Europe Plasma-derived Factor VIII by Countries
7.1.1 Europe Plasma-derived Factor VIII Consumption by Countries (2015-2020)
7.1.2 Europe Plasma-derived Factor VIII Value by Countries (2015-2020)
7.2 Europe Plasma-derived Factor VIII Consumption 2
7.3 Europe Plasma-derived Factor VIII Consumption 2
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa Plasma-derived Factor VIII by Countries
8.1.1 Middle East & Africa Plasma-derived Factor VIII Consumption by Countries (2015-2020)
8.1.2 Middle East & Africa Plasma-derived Factor VIII Value by Countries (2015-2020)
8.2 Middle East & Africa Plasma-derived Factor VIII Consumption 2
8.3 Middle East & Africa Plasma-derived Factor VIII Consumption 2
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Plasma-derived Factor VIII Distributors
10.3 Plasma-derived Factor VIII Customer
11 Global Plasma-derived Factor VIII Market Forecast
11.1 Global Plasma-derived Factor VIII Consumption Forecast (2021-2025)
11.2 Global Plasma-derived Factor VIII Forecast by Regions
11.2.1 Global Plasma-derived Factor VIII Forecast by Regions (2021-2025)
11.2.2 Global Plasma-derived Factor VIII Value Forecast by Regions (2021-2025)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast byRegions
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Plasma-derived Factor VIII Forecast 2
11.8 Global Plasma-derived Factor VIII Forecast 2
12 Key Players Analysis
12.1 Takeda
12.1.1 Company Information
12.1.2 Plasma-derived Factor VIII Product Offered
12.1.3 Takeda Plasma-derived Factor VIII Sales, Revenue, Price and Gross Margin (2018-2020)
12.1.4 Main Business Overview
12.1.5 Takeda Latest Developments
12.2 Octapharma
12.2.1 Company Information
12.2.2 Plasma-derived Factor VIII Product Offered
12.2.3 Octapharma Plasma-derived Factor VIII Sales, Revenue, Price and Gross Margin (2018-2020)
12.2.4 Main Business Overview
12.2.5 Octapharma Latest Developments
12.3 Grifols
12.3.1 Company Information
12.3.2 Plasma-derived Factor VIII Product Offered
12.3.3 Grifols Plasma-derived Factor VIII Sales, Revenue, Price and Gross Margin (2018-2020)
12.3.4 Main Business Overview
12.3.5 Grifols Latest Developments
12.4 Greencross
12.4.1 Company Information
12.4.2 Plasma-derived Factor VIII Product Offered
12.4.3 Greencross Plasma-derived Factor VIII Sales, Revenue, Price and Gross Margin (2018-2020)
12.4.4 Main Business Overview
12.4.5 Greencross Latest Developments
12.5 CSL
12.5.1 Company Information
12.5.2 Plasma-derived Factor VIII Product Offered
12.5.3 CSL Plasma-derived Factor VIII Sales, Revenue, Price and Gross Margin (2018-2020)
12.5.4 Main Business Overview
12.5.5 CSL Latest Developments
12.6 Hualan Bio
12.6.1 Company Information
12.6.2 Plasma-derived Factor VIII Product Offered
12.6.3 Hualan Bio Plasma-derived Factor VIII Sales, Revenue, Price and Gross Margin (2018-2020)
12.6.4 Main Business Overview
12.6.5 Hualan Bio Latest Developments
12.7 Kedrion
12.7.1 Company Information
12.7.2 Plasma-derived Factor VIII Product Offered
12.7.3 Kedrion Plasma-derived Factor VIII Sales, Revenue, Price and Gross Margin (2018-2020)
12.7.4 Main Business Overview
12.7.5 Kedrion Latest Developments
12.8 RAAS
12.8.1 Company Information
12.8.2 Plasma-derived Factor VIII Product Offered
12.8.3 RAAS Plasma-derived Factor VIII Sales, Revenue, Price and Gross Margin (2018-2020)
12.8.4 Main Business Overview
12.8.5 RAAS Latest Developments
12.9 BPL
12.9.1 Company Information
12.9.2 Plasma-derived Factor VIII Product Offered
12.9.3 BPL Plasma-derived Factor VIII Sales, Revenue, Price and Gross Margin (2018-2020)
12.9.4 Main Business Overview
12.9.5 BPL Latest Developments
13 Research Findings and Conclusion
Tables and Figures
List of Tables
Table 1. Research Methodology
Table 2. Data Source
Table 3. Plasma-derived Factor VIII Consumption CAGR by Region 2015-2025 ($ Millions)
Table 4. Major Players of 200IU
Table 5. Major Players of 250IU
Table 6. Global Consumption Sales 2 (2015-2020)
Table 7. Global Plasma-derived Factor VIII Consumption Market Share 2 (2015-2020)
Table 8. Global Plasma-derived Factor VIII Revenue 2 (2015-2020) ($ million)
Table 9. Global Plasma-derived Factor VIII Value Market Share 2 (2015-2020) ($ Millions)
Table 10. Global Plasma-derived Factor VIII Sale Price 2 (2015-2020)
Table 11. Global Consumption Sales 2 (2015-2020)
Table 12. Global Plasma-derived Factor VIII Consumption Market Share 2 (2015-2020)
Table 13. Global Plasma-derived Factor VIII Value 2 (2015-2020)
Table 14. Global Plasma-derived Factor VIII Value Market Share 2 (2015-2020)
Table 15. Global Plasma-derived Factor VIII Sale Price 2 (2015-2020)
Table 16. Global Plasma-derived Factor VIII Sales by Company (2017-2019) (K Units)
Table 17. Global Plasma-derived Factor VIII Sales Market Share by Company (2017-2019)
Table 18. Global Plasma-derived Factor VIII Revenue by Company (2017-2019) ($ Millions)
Table 19. Global Plasma-derived Factor VIII Revenue Market Share by Company (2017-2019)
Table 20. Global Plasma-derived Factor VIII Sale Price by Company (2017-2019)
Table 21. Global Plasma-derived Factor VIII Manufacturing Base Distribution and Sales Area by Manufacturers
Table 22. Players Plasma-derived Factor VIII Products Offered
Table 23. Plasma-derived Factor VIII Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
Table 24. Global Plasma-derived Factor VIII Consumption by Regions 2015-2020 (K Units)
Table 25. Global Plasma-derived Factor VIII Consumption Market Share by Regions 2015-2020
Table 26. Global Plasma-derived Factor VIII Value by Regions 2015-2020 ($ Millions)
Table 27. Global Plasma-derived Factor VIII Value Market Share by Regions 2015-2020
Table 28. Americas Plasma-derived Factor VIII Consumption by Countries (2015-2020) (K Units)
Table 29. Americas Plasma-derived Factor VIII Consumption Market Share by Countries (2015-2020)
Table 30. Americas Plasma-derived Factor VIII Value by Countries (2015-2020) ($ Millions)
Table 31. Americas Plasma-derived Factor VIII Value Market Share by Countries (2015-2020)
Table 32. Americas Plasma-derived Factor VIII Consumption by Type (2015-2020) (K Units)
Table 33. Americas Plasma-derived Factor VIII Consumption Market Share 2 (2015-2020)
Table 34. Americas Plasma-derived Factor VIII Consumption 2 (2015-2020) (K Units)
Table 35. Americas Plasma-derived Factor VIII Consumption Market Share 2 (2015-2020)
Table 36. APAC Plasma-derived Factor VIII Consumption by Regions (2015-2020) (K Units)
Table 37. APAC Plasma-derived Factor VIII Consumption Market Share by Regions (2015-2020)
Table 38. APAC Plasma-derived Factor VIII Value by Regions (2015-2020) ($ Millions)
Table 39. APAC Plasma-derived Factor VIII Value Market Share by Regions (2015-2020)
Table 40. APAC Plasma-derived Factor VIII Consumption 2 (2015-2020) (K Units)
Table 41. APAC Plasma-derived Factor VIII Consumption Market Share 2 (2015-2020)
Table 42. APAC Plasma-derived Factor VIII Consumption 2 (2015-2020) (K Units)
Table 43. APAC Plasma-derived Factor VIII Consumption Market Share 2 (2015-2020)
Table 44. Europe Plasma-derived Factor VIII Consumption by Countries (2015-2020) (K Units)
Table 45. Europe Plasma-derived Factor VIII Consumption Market Share by Countries (2015-2020)
Table 46. Europe Plasma-derived Factor VIII Value by Countries (2015-2020) ($ Millions)
Table 47. Europe Plasma-derived Factor VIII Value Market Share by Countries (2015-2020)
Table 48. Europe Plasma-derived Factor VIII Consumption by Type (2015-2020) (K Units)
Table 49. Europe Plasma-derived Factor VIII Consumption Market Share 2 (2015-2020)
Table 50. Europe Plasma-derived Factor VIII Consumption 2 (2015-2020) (K Units)
Table 51. Europe Plasma-derived Factor VIII Consumption Market Share 2 (2015-2020)
Table 52. Middle East & Africa Plasma-derived Factor VIII Consumption by Countries (2015-2020) (K Units)
Table 53. Middle East & Africa Plasma-derived Factor VIII Consumption Market Share by Countries (2015-2020)
Table 54. Middle East & Africa Plasma-derived Factor VIII Value by Countries (2015-2020) ($ Millions)
Table 55. Middle East & Africa Plasma-derived Factor VIII Value Market Share by Countries (2015-2020)
Table 56. Middle East & Africa Plasma-derived Factor VIII Consumption 2 (2015-2020) (K Units)
Table 57. Middle East & Africa Plasma-derived Factor VIII Consumption Market Share 2 (2015-2020)
Table 58. Middle East & Africa Plasma-derived Factor VIII Consumption 2 (2015-2020) (K Units)
Table 59. Middle East & Africa Plasma-derived Factor VIII Consumption Market Share 2 (2015-2020)
Table 60. Plasma-derived Factor VIII Distributors List
Table 61. Plasma-derived Factor VIII Customer List
Table 62. Global Plasma-derived Factor VIII Consumption Forecast by Countries (2021-2025) (K Units)
Table 63. Global Plasma-derived Factor VIII Consumption Market Forecast by Regions
Table 64. Global Plasma-derived Factor VIII Value Forecast by Countries (2021-2025) ($ Millions)
Table 65. Global Plasma-derived Factor VIII Value Market Share Forecast by Regions
Table 66. Global Plasma-derived Factor VIII Consumption Forecast 2 (2021-2025) (K Units)
Table 67. Global Plasma-derived Factor VIII Consumption Market Share Forecast 2 (2021-2025)
Table 68. Global Plasma-derived Factor VIII Value Forecast 2 (2021-2025) ($ Millions)
Table 69. Global Plasma-derived Factor VIII Value Market Share Forecast 2 (2021-2025)
Table 70. Global Plasma-derived Factor VIII Consumption Forecast 2 (2021-2025) (K Units)
Table 71. Global Plasma-derived Factor VIII Consumption Market Share Forecast 2 (2021-2025)
Table 72. Global Plasma-derived Factor VIII Value Forecast 2 (2021-2025) ($ Millions)
Table 73. Global Plasma-derived Factor VIII Value Market Share Forecast 2 (2021-2025)
Table 74. Takeda Product Offered
Table 75. Takeda Plasma-derived Factor VIII Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 76. Takeda Main Business
Table 77. Takeda Latest Developments
Table 78. Takeda Basic Information, Company Total Revenue (in $ million), Plasma-derived Factor VIII Manufacturing Base, Sales Area and Its Competitors
Table 79. Octapharma Product Offered
Table 80. Octapharma Plasma-derived Factor VIII Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 81. Octapharma Main Business
Table 82. Octapharma Latest Developments
Table 83. Octapharma Basic Information, Company Total Revenue (in $ million), Plasma-derived Factor VIII Manufacturing Base, Sales Area and Its Competitors
Table 84. Grifols Product Offered
Table 85. Grifols Plasma-derived Factor VIII Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 86. Grifols Main Business
Table 87. Grifols Latest Developments
Table 88. Grifols Basic Information, Company Total Revenue (in $ million), Plasma-derived Factor VIII Manufacturing Base, Sales Area and Its Competitors
Table 89. Greencross Product Offered
Table 90. Greencross Plasma-derived Factor VIII Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 91. Greencross Main Business
Table 92. Greencross Latest Developments
Table 93. Greencross Basic Information, Company Total Revenue (in $ million), Plasma-derived Factor VIII Manufacturing Base, Sales Area and Its Competitors
Table 94. CSL Product Offered
Table 95. CSL Plasma-derived Factor VIII Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 96. CSL Main Business
Table 97. CSL Latest Developments
Table 98. CSL Basic Information, Company Total Revenue (in $ million), Plasma-derived Factor VIII Manufacturing Base, Sales Area and Its Competitors
Table 99. Hualan Bio Product Offered
Table 100. Hualan Bio Plasma-derived Factor VIII Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 101. Hualan Bio Main Business
Table 102. Hualan Bio Latest Developments
Table 103. Hualan Bio Basic Information, Company Total Revenue (in $ million), Plasma-derived Factor VIII Manufacturing Base, Sales Area and Its Competitors
Table 104. Kedrion Product Offered
Table 105. Kedrion Basic Information, Company Total Revenue (in $ million), Plasma-derived Factor VIII Manufacturing Base, Sales Area and Its Competitors
Table 106. Kedrion Main Business
Table 107. Kedrion Latest Developments
Table 108. Kedrion Plasma-derived Factor VIII Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 109. RAAS Product Offered
Table 110. RAAS Plasma-derived Factor VIII Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 111. RAAS Main Business
Table 112. RAAS Latest Developments
Table 113. RAAS Basic Information, Company Total Revenue (in $ million), Plasma-derived Factor VIII Manufacturing Base, Sales Area and Its Competitors
Table 114. BPL Product Offered
Table 115. BPL Plasma-derived Factor VIII Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 116. BPL Main Business
Table 117. BPL Latest Developments
Table 118. BPL Basic Information, Company Total Revenue (in $ million), Plasma-derived Factor VIII Manufacturing Base, Sales Area and Its Competitors
List of Figures
Figure 1. Picture of Plasma-derived Factor VIII
Figure 2. Plasma-derived Factor VIII Report Years Considered
Figure 3. Market Research Methodology
Figure 4. Global Plasma-derived Factor VIII Consumption Growth Rate 2015-2025 (K Units)
Figure 5. Global Plasma-derived Factor VIII Value Growth Rate 2015-2025 ($ Millions)
Figure 6. Product Picture of 200IU
Figure 7. Product Picture of 250IU
Figure 8. Global Plasma-derived Factor VIII Consumption Market Share 2 (2015-2020)
Figure 9. Global Plasma-derived Factor VIII Value Market Share 2 (2015-2020)
Figure 10. Plasma-derived Factor VIII Consumed in Hospital
Figure 11. Global Plasma-derived Factor VIII Market: Hospital (2015-2020) (K Units)
Figure 12. Global Plasma-derived Factor VIII Market: Hospital (2015-2020) ($ Millions)
Figure 13. Plasma-derived Factor VIII Consumed in Pharmacy
Figure 14. Global Plasma-derived Factor VIII Market: Pharmacy (2015-2020) (K Units)
Figure 15. Global Plasma-derived Factor VIII Market: Pharmacy (2015-2020) ($ Millions)
Figure 16. Global Plasma-derived Factor VIII Consumption Market Share 2 (2015-2020)
Figure 17. Global Plasma-derived Factor VIII Value Market Share 2 (2015-2020)
Figure 18. Global Plasma-derived Factor VIII Sales Market Share by Company in 2017
Figure 19. Global Plasma-derived Factor VIII Sales Market Share by Company in 2019
Figure 20. Global Plasma-derived Factor VIII Revenue Market Share by Company in 2017
Figure 21. Global Plasma-derived Factor VIII Revenue Market Share by Company in 2019
Figure 22. Global Plasma-derived Factor VIII Sale Price by Company in 2019
Figure 23. Global Plasma-derived Factor VIII Consumption Market Share by Regions 2015-2020
Figure 24. Global Plasma-derived Factor VIII Value Market Share by Regions 2015-2020
Figure 25. Americas Plasma-derived Factor VIII Consumption 2015-2020 (K Units)
Figure 26. Americas Plasma-derived Factor VIII Value 2015-2020 ($ Millions)
Figure 27. APAC Plasma-derived Factor VIII Consumption 2015-2020 (K Units)
Figure 28. APAC Plasma-derived Factor VIII Value 2015-2020 ($ Millions)
Figure 29. Europe Plasma-derived Factor VIII Consumption 2015-2020 (K Units)
Figure 30. Europe Plasma-derived Factor VIII Value 2015-2020 ($ Millions)
Figure 31. Middle East & Africa Plasma-derived Factor VIII Consumption 2015-2020 (K Units)
Figure 32. Middle East & Africa Plasma-derived Factor VIII Value 2015-2020 ($ Millions)
Figure 33. Americas Plasma-derived Factor VIII Consumption Market Share by Countries in 2019
Figure 34. Americas Plasma-derived Factor VIII Value Market Share by Countries in 2019
Figure 35. Americas Plasma-derived Factor VIII Consumption Market Share 2 in 2019
Figure 36. Americas Plasma-derived Factor VIII Consumption Market Share 2 in 2019
Figure 37. United States Plasma-derived Factor VIII Consumption Growth 2015-2020 (K Units)
Figure 38. United States Plasma-derived Factor VIII Value Growth 2015-2020 ($ Millions)
Figure 39. Canada Plasma-derived Factor VIII Consumption Growth 2015-2020 (K Units)
Figure 40. Canada Plasma-derived Factor VIII Value Growth 2015-2020 ($ Millions)
Figure 41. Mexico Plasma-derived Factor VIII Consumption Growth 2015-2020 (K Units)
Figure 42. Mexico Plasma-derived Factor VIII Value Growth 2015-2020 ($ Millions)
Figure 43. APAC Plasma-derived Factor VIII Consumption Market Share by Countries in 2019
Figure 44. APAC Plasma-derived Factor VIII Value Market Share by Regions in 2019
Figure 45. APAC Plasma-derived Factor VIII Consumption Market Share 2 in 2019
Figure 46. APAC Plasma-derived Factor VIII Consumption Market Share 2 in 2019
Figure 47. China Plasma-derived Factor VIII Consumption Growth 2015-2020 (K Units)
Figure 48. China Plasma-derived Factor VIII Value Growth 2015-2020 ($ Millions)
Figure 49. Japan Plasma-derived Factor VIII Consumption Growth 2015-2020 (K Units)
Figure 50. Japan Plasma-derived Factor VIII Value Growth 2015-2020 ($ Millions)
Figure 51. Korea Plasma-derived Factor VIII Consumption Growth 2015-2020 (K Units)
Figure 52. Korea Plasma-derived Factor VIII Value Growth 2015-2020 ($ Millions)
Figure 53. Southeast Asia Plasma-derived Factor VIII Consumption Growth 2015-2020 (K Units)
Figure 54. Southeast Asia Plasma-derived Factor VIII Value Growth 2015-2020 ($ Millions)
Figure 55. India Plasma-derived Factor VIII Consumption Growth 2015-2020 (K Units)
Figure 56. India Plasma-derived Factor VIII Value Growth 2015-2020 ($ Millions)
Figure 57. Australia Plasma-derived Factor VIII Consumption Growth 2015-2020 (K Units)
Figure 58. Australia Plasma-derived Factor VIII Value Growth 2015-2020 ($ Millions)
Figure 59. Europe Plasma-derived Factor VIII Consumption Market Share by Countries in 2019
Figure 60. Europe Plasma-derived Factor VIII Value Market Share by Countries in 2019
Figure 61. Europe Plasma-derived Factor VIII Consumption Market Share 2 in 2019
Figure 62. Europe Plasma-derived Factor VIII Consumption Market Share 2 in 2019
Figure 63. Germany Plasma-derived Factor VIII Consumption Growth 2015-2020 (K Units)
Figure 64. Germany Plasma-derived Factor VIII Value Growth 2015-2020 ($ Millions)
Figure 65. France Plasma-derived Factor VIII Consumption Growth 2015-2020 (K Units)
Figure 66. France Plasma-derived Factor VIII Value Growth 2015-2020 ($ Millions)
Figure 67. UK Plasma-derived Factor VIII Consumption Growth 2015-2020 (K Units)
Figure 68. UK Plasma-derived Factor VIII Value Growth 2015-2020 ($ Millions)
Figure 69. Italy Plasma-derived Factor VIII Consumption Growth 2015-2020 (K Units)
Figure 70. Italy Plasma-derived Factor VIII Value Growth 2015-2020 ($ Millions)
Figure 71. Russia Plasma-derived Factor VIII Consumption Growth 2015-2020 (K Units)
Figure 72. Russia Plasma-derived Factor VIII Value Growth 2015-2020 ($ Millions)
Figure 73. Middle East & Africa Plasma-derived Factor VIII Consumption Market Share by Countries in 2019
Figure 74. Middle East & Africa Plasma-derived Factor VIII Value Market Share by Countries in 2019
Figure 75. Middle East & Africa Plasma-derived Factor VIII Consumption Market Share 2 in 2019
Figure 76. Middle East & Africa Plasma-derived Factor VIII Consumption Market Share 2 in 2019
Figure 77. Egypt Plasma-derived Factor VIII Consumption Growth 2015-2020 (K Units)
Figure 78. Egypt Plasma-derived Factor VIII Value Growth 2015-2020 ($ Millions)
Figure 79. South Africa Plasma-derived Factor VIII Consumption Growth 2015-2020 (K Units)
Figure 80. South Africa Plasma-derived Factor VIII Value Growth 2015-2020 ($ Millions)
Figure 81. Israel Plasma-derived Factor VIII Consumption Growth 2015-2020 (K Units)
Figure 82. Israel Plasma-derived Factor VIII Value Growth 2015-2020 ($ Millions)
Figure 83. Turkey Plasma-derived Factor VIII Consumption Growth 2015-2020 (K Units)
Figure 84. Turkey Plasma-derived Factor VIII Value Growth 2015-2020 ($ Millions)
Figure 85. GCC Countries Plasma-derived Factor VIII Consumption Growth 2015-2020 (K Units)
Figure 86. GCC Countries Plasma-derived Factor VIII Value Growth 2015-2020 ($ Millions)
Figure 87. Global Plasma-derived Factor VIII Consumption Growth Rate Forecast (2021-2025) (K Units)
Figure 88. Global Plasma-derived Factor VIII Value Growth Rate Forecast (2021-2025) ($ Millions)
Figure 89. Americas Plasma-derived Factor VIII Consumption 2021-2025 (K Units)
Figure 90. Americas Plasma-derived Factor VIII Value 2021-2025 ($ Millions)
Figure 91. APAC Plasma-derived Factor VIII Consumption 2021-2025 (K Units)
Figure 92. APAC Plasma-derived Factor VIII Value 2021-2025 ($ Millions)
Figure 93. Europe Plasma-derived Factor VIII Consumption 2021-2025 (K Units)
Figure 94. Europe Plasma-derived Factor VIII Value 2021-2025 ($ Millions)
Figure 95. Middle East & Africa Plasma-derived Factor VIII Consumption 2021-2025 (K Units)
Figure 96. Middle East & Africa Plasma-derived Factor VIII Value 2021-2025 ($ Millions)
Figure 97. United States Plasma-derived Factor VIII Consumption 2021-2025 (K Units)
Figure 98. United States Plasma-derived Factor VIII Value 2021-2025 ($ Millions)
Figure 99. Canada Plasma-derived Factor VIII Consumption 2021-2025 (K Units)
Figure 100. Canada Plasma-derived Factor VIII Value 2021-2025 ($ Millions)
Figure 101. Mexico Plasma-derived Factor VIII Consumption 2021-2025 (K Units)
Figure 102. Mexico Plasma-derived Factor VIII Value 2021-2025 ($ Millions)
Figure 103. Brazil Plasma-derived Factor VIII Consumption 2021-2025 (K Units)
Figure 104. Brazil Plasma-derived Factor VIII Value 2021-2025 ($ Millions)
Figure 105. China Plasma-derived Factor VIII Consumption 2021-2025 (K Units)
Figure 106. China Plasma-derived Factor VIII Value 2021-2025 ($ Millions)
Figure 107. Japan Plasma-derived Factor VIII Consumption 2021-2025 (K Units)
Figure 108. Japan Plasma-derived Factor VIII Value 2021-2025 ($ Millions)
Figure 109. Korea Plasma-derived Factor VIII Consumption 2021-2025 (K Units)
Figure 110. Korea Plasma-derived Factor VIII Value 2021-2025 ($ Millions)
Figure 111. Southeast Asia Plasma-derived Factor VIII Consumption 2021-2025 (K Units)
Figure 112. Southeast Asia Plasma-derived Factor VIII Value 2021-2025 ($ Millions)
Figure 113. India Plasma-derived Factor VIII Consumption 2021-2025 (K Units)
Figure 114. India Plasma-derived Factor VIII Value 2021-2025 ($ Millions)
Figure 115. Australia Plasma-derived Factor VIII Consumption 2021-2025 (K Units)
Figure 116. Australia Plasma-derived Factor VIII Value 2021-2025 ($ Millions)
Figure 117. Germany Plasma-derived Factor VIII Consumption 2021-2025 (K Units)
Figure 118. Germany Plasma-derived Factor VIII Value 2021-2025 ($ Millions)
Figure 119. France Plasma-derived Factor VIII Consumption 2021-2025 (K Units)
Figure 120. France Plasma-derived Factor VIII Value 2021-2025 ($ Millions)
Figure 121. UK Plasma-derived Factor VIII Consumption 2021-2025 (K Units)
Figure 122. UK Plasma-derived Factor VIII Value 2021-2025 ($ Millions)
Figure 123. Italy Plasma-derived Factor VIII Consumption 2021-2025 (K Units)
Figure 124. Italy Plasma-derived Factor VIII Value 2021-2025 ($ Millions)
Figure 125. Russia Plasma-derived Factor VIII Consumption 2021-2025 (K Units)
Figure 126. Russia Plasma-derived Factor VIII Value 2021-2025 ($ Millions)
Figure 127. Spain Plasma-derived Factor VIII Consumption 2021-2025 (K Units)
Figure 128. Spain Plasma-derived Factor VIII Value 2021-2025 ($ Millions)
Figure 129. Egypt Plasma-derived Factor VIII Consumption 2021-2025 (K Units)
Figure 130. Egypt Plasma-derived Factor VIII Value 2021-2025 ($ Millions)
Figure 131. South Africa Plasma-derived Factor VIII Consumption 2021-2025 (K Units)
Figure 132. South Africa Plasma-derived Factor VIII Value 2021-2025 ($ Millions)
Figure 133. Israel Plasma-derived Factor VIII Consumption 2021-2025 (K Units)
Figure 134. Israel Plasma-derived Factor VIII Value 2021-2025 ($ Millions)
Figure 135. Turkey Plasma-derived Factor VIII Consumption 2021-2025 (K Units)
Figure 136. Turkey Plasma-derived Factor VIII Value 2021-2025 ($ Millions)
Figure 137. GCC Countries Plasma-derived Factor VIII Consumption 2021-2025 (K Units)
Figure 138. GCC Countries Plasma-derived Factor VIII Value 2021-2025 ($ Millions)
Figure 139. Takeda Plasma-derived Factor VIII Market Share (2018-2020)
Figure 140. Octapharma Plasma-derived Factor VIII Market Share (2018-2020)
Figure 141. Grifols Plasma-derived Factor VIII Market Share (2018-2020)
Figure 142. Greencross Plasma-derived Factor VIII Market Share (2018-2020)
Figure 143. CSL Plasma-derived Factor VIII Market Share (2018-2020)
Figure 144. Hualan Bio Plasma-derived Factor VIII Market Share (2018-2020)
Figure 145. Kedrion Plasma-derived Factor VIII Market Share (2018-2020)
Figure 146. RAAS Plasma-derived Factor VIII Market Share (2018-2020)
Figure 147. BPL Plasma-derived Factor VIII Market Share (2018-2020)
Reason to Buy
- Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
- Highlights key business priorities in order to assist companies to realign their business strategies
- The segment that is expected to dominate the Pharma & Healthcare Market
- Regions that are expected to witness the fastest growth during the forecast period
- Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets